Meryx
Latest round
- Series A
Last raised
- Jan 2015
Total raised
- $1.5M
Investors
- 1
About Meryx
Meryx Inc. is a pharmaceutical company focused on developing innovative products aimed at addressing unmet medical needs., headquartered in Chapel Hill, US, specializes in pharmaceutical development. In December 2021, Tyrogenex Inc. acquired a majority stake from Eshelman Ventures.Meryx Pharma specializes in developing innovative pharmaceutical products designed to address unmet medical needs across various therapeutic areas. The company's core offerings include prescription medications that target chronic diseases, ensuring improved patient outcomes through advanced formulations and delivery systems. These products are primarily marketed to healthcare providers, hospitals, and specialty pharmacies, focusing on enhancing the quality of life for patients suffering from conditions such as cardiovascular disorders and autoimmune diseases.Meryx Pharma generates revenue through a combination of direct sales and partnerships with healthcare organizations. The company engages in business-to-business transactions, supplying its pharmaceutical products to hospitals and clinics while also establishing collaborations with wholesalers to expand distribution channels. Revenue is structured around product sales, with pricing models based on negotiated agreements with institutional clients and volume-based discounts for large orders. Flagship products contribute significantly to the firm's revenue stream, as they are in high demand within the healthcare market.Meryx Inc. The company is also focused on launching new products aimed at chronic disease management, with expectations for rollouts in the coming years. Expansion efforts are targeted toward new international markets, including additional regions in Asia and Europe, to diversify their market presence and reach more patients.
Who invested in Meryx
1 investor across 1 round
See all investors in Meryx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 1, 2015
Amount
$1.5M
Investors
Questions about Meryx
Who invested in Meryx?
Meryx has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Meryx raised?
Meryx has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Meryx last raise money?
Meryx's most recent round on record is a Series A, in Jan 2015.
What does Meryx do?
Meryx is a biotechnology company.
Where is Meryx headquartered?
Meryx is headquartered in Chapel Hill, US.
Which VCs invest in companies like Meryx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Meryx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Meryx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.